BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27814639)

  • 1. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome.
    Febo M; Blum K; Badgaiyan RD; Baron D; Thanos PK; Colon-Perez LM; Demortrovics Z; Gold MS
    Front Biosci (Landmark Ed); 2017 Jan; 22(4):669-691. PubMed ID: 27814639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
    Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
    J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
    Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
    Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
    J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reward and executive control network resting-state functional connectivity is associated with impulsivity during reward-based decision making for cocaine users.
    Hobkirk AL; Bell RP; Utevsky AV; Huettel S; Meade CS
    Drug Alcohol Depend; 2019 Jan; 194():32-39. PubMed ID: 30391836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit.
    Volkow ND; Wang GJ; Fowler JS; Tomasi D; Telang F; Baler R
    Bioessays; 2010 Sep; 32(9):748-55. PubMed ID: 20730946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addictive dimensionality of obesity.
    Volkow ND; Wang GJ; Tomasi D; Baler RD
    Biol Psychiatry; 2013 May; 73(9):811-8. PubMed ID: 23374642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.
    Bowirrat A; Oscar-Berman M
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):29-37. PubMed ID: 15457501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual roles of dopamine in food and drug seeking: the drive-reward paradox.
    Wise RA
    Biol Psychiatry; 2013 May; 73(9):819-26. PubMed ID: 23044182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
    Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
    Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction becomes a brain disease.
    Wise RA
    Neuron; 2000 Apr; 26(1):27-33. PubMed ID: 10798389
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging brain response to reward in addictive disorders.
    Hommer DW; Bjork JM; Gilman JM
    Ann N Y Acad Sci; 2011 Jan; 1216():50-61. PubMed ID: 21272010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.
    Jentsch JD; Taylor JR
    Psychopharmacology (Berl); 1999 Oct; 146(4):373-90. PubMed ID: 10550488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.